These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9627039)

  • 21. The effect of dialysis membrane on serum beta 2-microglobulin (beta 2M) in chronic haemodialysis patients.
    Farrell J; Bastani B
    Nephrol Dial Transplant; 1997 Apr; 12(4):856. PubMed ID: 9141041
    [No Abstract]   [Full Text] [Related]  

  • 22. How to interpret intratreatment changes in plasma beta-2-microglobulin concentrations.
    Marsen T; Hönig R; Schad S; Barth C; Pollok M; Baldamus CA
    Contrib Nephrol; 1989; 74():147-52. PubMed ID: 2702132
    [No Abstract]   [Full Text] [Related]  

  • 23. Increased levels of serum matrix metalloproteinase-3 in haemodialysis patients with dialysis-related amyloidosis.
    Naganuma T; Sugimura K; Uchida J; Tashiro K; Yoshimura R; Takemoto Y; Nakatani T
    Nephrology (Carlton); 2008 Apr; 13(2):104-8. PubMed ID: 18275497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uraemic itching: do polymethylmethacrylate dialysis membranes play a role?
    Aucella F; Vigilante M; Gesuete A; Maruccio G; Specchio A; Gesualdo L
    Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v8-12. PubMed ID: 17586845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medium Cut-Off (MCO) Membranes Reduce Inflammation in Chronic Dialysis Patients-A Randomized Controlled Clinical Trial.
    Zickler D; Schindler R; Willy K; Martus P; Pawlak M; Storr M; Hulko M; Boehler T; Glomb MA; Liehr K; Henning C; Templin M; Trojanowicz B; Ulrich C; Werner K; Fiedler R; Girndt M
    PLoS One; 2017; 12(1):e0169024. PubMed ID: 28085888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new synthetic dialyzer with advanced permselectivity for enhanced low-molecular weight protein removal.
    Krieter DH; Lemke HD; Wanner C
    Artif Organs; 2008 Jul; 32(7):547-54. PubMed ID: 18638309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel changes in beta2-microglobulin in dialysis patients.
    Winchester JF
    Clin Chem; 2005 Jul; 51(7):1089-90. PubMed ID: 15976094
    [No Abstract]   [Full Text] [Related]  

  • 28. Expression of beta2-microglobulin and c-fos mRNA: is there an influence of high- or low-flux dialyzer membranes?
    Haufe CC; Eismann U; Deppisch RM; Stein G
    Kidney Int Suppl; 2001 Feb; 78():S177-81. PubMed ID: 11169006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Removal of silicon, aluminum and beta 2-microglobulin in chronic haemodialysis patients.
    Hosokawa S; Yoshida O
    Int Urol Nephrol; 1991; 23(3):281-4. PubMed ID: 1889973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum low-molecular-weight proteins in haemodialysis patients: effect of residual renal function.
    Brown PH; Kalra PA; Turney JH; Cooper EH
    Nephrol Dial Transplant; 1988; 3(2):169-73. PubMed ID: 2459634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure of dialysis membranes and long-term clinical outcome.
    Bonomini V; Coli L; Scolari MP; Stefoni S
    Am J Nephrol; 1995; 15(6):455-62. PubMed ID: 8546165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Beta 2 microglobulin in the blood pf patients with chronic renal failure treated by hemodialysis and kidney transplantation].
    Wiecek A; Kokot F; Kochańska-Dziurowicz A; Grzeszczak W; Zukowska-Szczechowska E
    Pol Arch Med Wewn; 1989 Feb; 81(2):100-6. PubMed ID: 2694120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma dimethylarginine levels in chronic hemodialysis patients are independent of the type of dialyzer applied.
    Grooteman MP; Wauters IM; Teerlink T; Twisk JW; Nubé MJ
    Blood Purif; 2007; 25(3):281-9. PubMed ID: 17622710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical significance of beta 2 microglobulin determination in dialysis patients].
    Stein G; Carlsohn H; Schaefer K; Abendroth K; Marzoll I; Sperschneider H; Günther K; Wessel G
    Z Urol Nephrol; 1989 May; 82(5):265-72. PubMed ID: 2665386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence of cuprophane membrane surface dialyzers on beta2-microglobulin serum concentration in patients during hemodialysis].
    Szepietowski T; el-Hayek A
    Polim Med; 1993; 23(3-4):43-54. PubMed ID: 8029157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysis.
    Gerdemann A; Lemke HD; Nothdurft A; Heidland A; Münch G; Bahner U; Schinzel R
    Clin Nephrol; 2000 Oct; 54(4):276-83. PubMed ID: 11076103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnostic and therapeutic aspects of dialysis-related amyloidosis].
    Kopeć J
    Przegl Lek; 2006; 63(7):567-72. PubMed ID: 17203811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The removal efficiency of beta 2-microglobulin, alpha 1-microglobulin and alpha 1-acid glycoprotein by using dialyzers in the bloodstream and transference of endotoxin through membranes].
    Ueyama S; Kiyomizu S; Endo K; Nagayama N; Oda K; Ohashi T; Yamashita W; Harada R; Arima T
    Fukuoka Igaku Zasshi; 1990 Nov; 81(11):355-8. PubMed ID: 1703122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The analysis of plasma beta 2-microglobulin concentration in patients with chronic renal failure treated by hemodialysis].
    Król Z; Morawska Z
    Pediatr Pol; 1996 Feb; 71(2):121-5. PubMed ID: 8966077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of membrane permeability on inflammation and arterial stiffness: a randomized trial.
    Li PK; Cheng YL; Leung CB; Szeto CC; Chow KM; Kwan BC; Ng ES; Fok QW; Poon YL; Yu AW
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):652-8. PubMed ID: 20203165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.